Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies
- PMID: 1916888
- PMCID: PMC1384562
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies
Abstract
The importance of the dependence on single amino acids in the V3 region of HIV-1 gp120 was evaluated for virus neutralization and antibody-dependent cellular cytotoxicity (ADCC). Synthetic overlapping 15-mer peptides and a set of omission peptides covering amino acids 301-317 were used. Sera from 29 HIV-1-infected individuals at different stages of disease were tested for neutralization, ADCC and specific IgG reactivity. Six HIV-1 neutralizing monoclonal antibodies (mAb) acted as controls. All mAb reacted with a region (amino acids 304-318) of gp120, previously shown to induce neutralizing antibodies. The amino acids essential for reactivity were identified to be within the sequence GPGR (amino acids 312-315). The importance of this region for occurrence of neutralizing antibodies in infected humans was investigated using the same set of peptides. Out of 29 individuals, 21 were found to have neutralizing antibodies in titres between 100 and 1000. Among the neutralization-positive sera, 17/21 (81%) reacted with amino acids 304-318, compared with only one of eight sera (13%) negative in neutralization. When any of the four amino acids G, P, G or R were deleted, the seroreactivity decreased considerably. The conserved sequence GPGR was therefore considered to be the most important for neutralization in this region in human sera as well. Thus, the conserved sequence GPGR in the V3 region of gp120 is critical for virus neutralization by human HIV-1-specific antibodies.
Similar articles
-
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002. AIDS. 1993. PMID: 8363754
-
Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.Arch Virol. 1992;127(1-4):139-52. doi: 10.1007/BF01309580. Arch Virol. 1992. PMID: 1456889
-
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.J Virol. 1992 Mar;66(3):1823-31. doi: 10.1128/JVI.66.3.1823-1831.1992. J Virol. 1992. PMID: 1637373 Free PMC article.
-
The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.AIDS Res Hum Retroviruses. 2004 Nov;20(11):1254-8. doi: 10.1089/aid.2004.20.1254. AIDS Res Hum Retroviruses. 2004. PMID: 15588347
-
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):461-5. doi: 10.1073/pnas.89.2.461. Proc Natl Acad Sci U S A. 1992. PMID: 1370580 Free PMC article.
Cited by
-
HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.PLoS One. 2013 Sep 9;8(9):e75277. doi: 10.1371/journal.pone.0075277. eCollection 2013. PLoS One. 2013. PMID: 24040404 Free PMC article.
-
Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.Immunology. 1994 Mar;81(3):428-34. Immunology. 1994. PMID: 7515847 Free PMC article.
-
Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.J Virol. 1996 Jul;70(7):4598-606. doi: 10.1128/JVI.70.7.4598-4606.1996. J Virol. 1996. PMID: 8676486 Free PMC article.
-
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.Virol J. 2014 Jun 16;11:112. doi: 10.1186/1743-422X-11-112. Virol J. 2014. PMID: 24935650 Free PMC article.
-
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.J Clin Microbiol. 2002 Jun;40(6):2141-6. doi: 10.1128/JCM.40.6.2141-2146.2002. J Clin Microbiol. 2002. PMID: 12037078 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous